Chemed Corporation reiterates earnings guidance for full year 2024. For the full year, company reiterates earnings per diluted share, excluding: non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, and other discrete items, guidance range of $23.30 to $23.70.